Werner Krammer: How Escitalopram Can Support Motor Recovery Post Cortical Sensori-Motor Stroke
Werner Krammer, Senior Physician at Zihlschlacht Rehabilitation Clinic, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
‘‘I am excited to share our latest research from the Support Center for Advanced Neuroimaging (SCAN) at the Inselspital, University Hospital Bern.
In our recent longitudinal study, we explored how Escitalopram can support motor recovery following cortical sensori-motor stroke.
Our findings suggest that the medication promotes significant recovery from hand paresis, offering a promising avenue for enhancing post-stroke rehabilitation.
A huge thank you to my colleagues and the entire team for their dedication to advancing neuro-rehabilitation.”
Title: Escitalopram promotes recovery from hand paresis in cortical sensori-motor stroke: a randomized, double-blind, placebo-controlled longitudinal study
Authors: Vanessa Vallesi, Werner Krammer, Andrea Federspiel, John H. Missimer, Manuela Pastore-Wapp, Georg Kägi, Roland Wiest, Bruno J. Weder
Read the Full Article on Journal of NeuroEngineering and Rehabilitation

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 14, 2026, 06:26Delivering Gene Therapy in Hemophilia – ISTH
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials